Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|August 21, 2003
NKIAMRE, a novel conserved CDC2-related kinase with features of both mitogen-activated protein kinases and cyclin-dependent kinasesKaren W L Yee, Susan J Moore, Michael Midmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic AdenocarcinomaSpring Holter, Ayelet Borgida, Anna Dodd, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 26, 2015
Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticleMark J Ernsting, Bryan Hoang, Ines Lohse, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2003
Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trialMichelle Nottage, Sue-Anne McLachlan, Mary-Anne Brittain, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcomaKårstein Måseide, Rita A Kandel, Robert S Bell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trialJennifer J Knox, David Hedley, Amit Oza, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2024
The CD8<sup>+</sup> T cell content of transbronchial biopsies from patients with a first episode of clinically stable grade A1 cellular rejection is associated with future chronic lung allograft dysfunctionSamuel A Beber, Sajad Moshkelgosha, Matthew White, et al.International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II studyAnthony Brade, James Brierley, Amit Oza, et al.Investigational New Drugs|April 29, 2011
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancerDaniel J Renouf, Patricia A Tang, Pierre Major, et al.Journal of Gastrointestinal Oncology|May 9, 2017
Long term responders to palliative chemotherapy for advanced biliary tract cancerMark K Doherty, Mairéad G McNamara, Priya Aneja, et al.Pageof 7